Drug intelligence / Profile preview

petasites hybridus extract + levocetirizine

Development stage
Preclinical
Lead developer
Max Zeller Söhne
Modality
Small Molecules
Administration
Oral
01

Overview

This is a **combination product** containing Petasites hybridus extract (commonly known as butterbur) and levocetirizine. - **Petasites hybridus extract** is a herbal remedy traditionally used for migraine prophylaxis, allergic rhinitis, and respiratory or gastrointestinal spasms. Its main active components, petasins (sesquiterpene esters), have anti-inflammatory properties. Butterbur acts by inhibiting inflammatory mediators (such as prostaglandins and leukotrienes), blocking L-type voltage-dependent calcium channels, suppressing CGRP (calcitonin gene-related peptide) release, and possibly inhibiting cyclooxygenase-2 (COX-2) activity and expression[1][2]. - **Levocetirizine** is a second-generation antihistamine and selective antagonist of the histamine H1 receptor, commonly used for allergic rhinitis and urticaria. It blocks peripheral H1 receptors, preventing the typical allergic and inflammatory responses triggered by histamine[3]. Combining these agents is rationalized by their complementary mechanisms for managing allergy-related symptoms, with butterbur adding anti-inflammatory and possible antispasmodic effects to levocetirizine’s antihistaminic action.

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)LTCC (Voltage-gated calcium channel (L-type))HRH1 (Histamine H1 Receptor)ALOX12 (Arachidonate 12-lipoxygenase, 12S type)

Beyond the preview

Go deeper on petasites hybridus extract + levocetirizine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on petasites hybridus extract + levocetirizine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call